Contraline is developing a portfolio of male contraceptive products to give men real choices in family planning.
| Candidate | Preclinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|
NES/Thormonal gel | Phase 2B Completed | |||
ADAMnon-hormonal implant | Phase 2 Ready |
A phase 2b clinical trial has been completed, demonstrating strong efficacy, safety, and reversibility. Phase 3 trial planning is now underway.

The first-in-human study on ADAM is complete, showing promising safety and efficacy. Planning for Phase 2 is underway.
